5-amino-1mq

5-Amino-1MQ: Comprehensive Research Guide

5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase, commonly abbreviated NNMT. This guide explains its chemical identity, the evidence behind its research interest, and practical questions to resolve before selecting a laboratory material. It separates findings from experimental models from claims about human outcomes. The product is intended for laboratory research, not for human or veterinary administration, self-experimentation, diagnosis, or treatment.

Researchers comparing materials should start with identity and documentation, not a headline about weight loss or longevity. A compound name alone does not establish the supplied salt, analytical purity, solution stability, or suitability for a particular assay. Review the selected product option, container label, safety data sheet, and available batch-specific analytical documentation before designing experiments.

Chemical Identity and Molecular Properties

The name 5-Amino-1MQ refers to 5-amino-1-methylquinolinium. Although this item appears in a catalog that also contains peptides, it is not an amino-acid chain and does not have a peptide sequence. The word “amino” describes a chemical functional group; it does not make the molecule a peptide. This distinction matters when choosing analytical methods, comparing published materials, and interpreting formulation instructions.

The existing catalog identifies an iodide salt. For that identified form, the listed formula is C10H11IN2 and the molecular weight is approximately 286.11 g/mol. These values should be checked against the actual batch identity before calculating molar concentrations. A counterion contributes mass to a salt, so the mass of the complete salt is not interchangeable with that of the quinolinium component alone. Researchers should record the exact form used in their laboratory notes and reports.

NNMT Inhibition: Mechanism and Interpretation

NNMT transfers a methyl group from S-adenosylmethionine to nicotinamide, generating 1-methylnicotinamide and S-adenosylhomocysteine. NNMT therefore connects nicotinamide handling with cellular methyl-donor metabolism. It does not directly consume NAD+. Describing its inhibition as a guaranteed increase in all NAD-dependent processes oversimplifies a network of competing reactions.

Published work on methylquinolinium inhibitors reported cellular NNMT inhibition and changes in nicotinamide-related metabolites in experimental systems. The early study also examined adipocyte biology and diet-induced obese mice. These findings support a research rationale, but enzyme inhibition is not equivalent to an established treatment effect. See the original NNMT inhibitor study for its models and experimental limitations.

For a new project, it is useful to separate three questions: does the material reach the experimental system, does it alter the intended target, and does a downstream biological measurement change? A single endpoint rarely answers all three. In particular, a change in a metabolic readout should not automatically be presented as direct activation of a sirtuin, improved mitochondrial function, or extended lifespan.

Preclinical Research Evidence

A 2021 mouse study evaluated NNMT inhibition together with a switch from an obesogenic diet to a lean diet. The combined intervention produced changes in body composition, liver adiposity, and the adipose metabolome compared with diet substitution alone. Diet was part of the experimental design, not an incidental detail. The results cannot establish a human weight-loss response, an effective consumer dose, or the safety of long-term use. The published mouse study provides the relevant comparison groups and outcome measures.

A separate analytical study developed and validated an LC-MS/MS method for measuring 5-amino-1-methylquinolinium in rat plasma and urine, then applied it to pharmacokinetic research. Its value here is evidence that exposure can be measured using a validated bioanalytical approach. Rat exposure data do not establish human bioavailability, and they do not validate any commercial capsule or powder formulation. Read the rat bioanalytical and pharmacokinetic study when evaluating analytical methods.

These publications address different questions. A mouse phenotype study and a rat assay-validation study should not be merged into a single claim that this catalog product has proven clinical benefits. Neither paper is a batch certificate for the material supplied here. Independent replication, model selection, exposure measurements, and appropriate controls remain important when extending published observations.

Product Specifications and Documentation Checklist

Item	Research reference or verification requirement
Product name	5-Amino-1MQ; 5-amino-1-methylquinolinium
Compound class	Small molecule; not a peptide
Research target	Nicotinamide N-methyltransferase (NNMT)
Catalog salt identity	Iodide; confirm against the supplied batch documentation
Formula and molecular weight	For the catalog-listed iodide: C10H11IN2; approximately 286.11 g/mol
Peptide sequence	Not applicable
Quantity and presentation	Check the selected product option and actual container label
Purity	Use the batch-specific result and analytical method; no unverified batch purity guarantee is made here
Identity testing	Review available identity data separately from chromatographic purity
Solubility and storage	Follow the applicable supplier documentation and validated laboratory method
Intended use	Laboratory research only; not for human or veterinary administration

A useful certificate of analysis identifies the material, batch number, test method, and reported result. Check that the document matches the batch received. Chromatographic peak-area purity is not the same as active content by mass, sterility, absence of endotoxin, or freedom from every possible impurity. If an experiment depends on any of these properties, request the relevant documentation rather than inferring it from a general purity percentage.

Laboratory Preparation, Handling, and Storage

Do not transfer a peptide reconstitution recipe to this small molecule without checking compatibility. Solvent choice depends on the confirmed material, required concentration, analytical method, and experimental matrix. A clear stock solution may still precipitate after dilution into a different buffer or medium. Establish preparation conditions through the responsible laboratory’s validated procedure, and include an appropriate vehicle control in experiments.

Document the solvent, preparation date, nominal concentration, calculation basis, container, and relevant storage conditions. Distinguish a concentration calculated from weighed material from one confirmed analytically. If purity or water content affects the calculation, state how that correction was made. Keep the original label and batch identifier associated with any secondary containers so that results remain traceable.

Use the current safety data sheet and institutional risk assessment to determine protective equipment, containment, waste disposal, and spill procedures. Avoid assuming that “research use” means harmless. Follow documented storage instructions for the supplied form and do not invent a universal shelf life for prepared solutions. Any claimed stability interval should match the solvent, concentration, temperature, and analytical acceptance criteria actually evaluated.

Planning Interpretable Research

Before collecting data, define the primary endpoint and what result would support or challenge the hypothesis. Consider vehicle controls, baseline measurements, independent biological replicates, and an orthogonal measure of target engagement. Record cell model identity, passage information where relevant, exposure duration, and the basis for excluding samples. These reporting practices make a result easier to interpret and reproduce.

Where metabolism is the question, distinguish substrate turnover, metabolite abundance, and a whole-system phenotype. They are related but not interchangeable. A change in cell number can influence a bulk assay signal, while vehicle effects or precipitation can complicate apparent concentration-response relationships. Include measurements that can reveal these alternative explanations rather than treating every change as a specific consequence of NNMT inhibition.

For regulated animal work, protocol design and oversight belong with the responsible institution. Published animal doses are not instructions for people, and translating them into self-administration advice is outside the purpose of this page. Report the model, controls, uncertainty, and study limitations alongside any positive result. A negative or model-dependent finding can also be scientifically informative.

Related Catalog Pages for Research Planning

The following links help researchers distinguish product identities and find separate documentation. They are not recommendations for combining substances, substitutes for a validated experimental protocol, or evidence that the listed materials share the same mechanism.

• 5-Amino-1MQ capsule listing: review this separately when comparing presentation and formulation; do not assume equivalence with the material on this page.
• SLU-PP-332 capsule listing: a distinct catalog item that requires its own identity and evidence review.
• MOTS-c: a separate peptide listing for researchers organizing a broader metabolism literature review.
• SS-31: consult its individual research description rather than attributing its literature to 5-Amino-1MQ.
• Humanin: another independently documented catalog entry, not a synonym or interchangeable material.
• Reduced glutathione: check its own chemical identity and handling information for relevant laboratory projects.
• Mazdutide: review separately when distinguishing research compounds discussed in metabolism-related literature.
• FOXO4-DRI: its individual evidence and experimental context must not be transferred to an NNMT inhibitor.

Frequently Asked Questions

1. Is 5-Amino-1MQ a peptide?

No. It is a small-molecule quinolinium compound. It has no peptide sequence, and its amino group does not make it an amino-acid chain. Use the complete chemical identity, including the supplied salt, when comparing documentation and calculating concentrations.

2. What is 5-Amino-1MQ studied for?

It is investigated as an NNMT inhibitor in preclinical research. The cited studies concern experimental metabolism, mouse phenotypes, and rat bioanalysis. This research interest should not be presented as proof that the catalog product treats obesity, diabetes, aging, or any other human condition.

3. Is there a recommended human dose?

This research product does not come with a human dosing recommendation. Animal or cell-culture conditions cannot be converted into a reliable self-administration regimen. Qualified researchers should select experimental conditions through the appropriate literature review, method development, and institutional approval processes.

4. Do published studies establish safety?

No. A result from a particular experimental model does not define a complete human safety profile. Short observation periods, limited endpoints, and selected study populations leave important uncertainties. Handle the material according to its safety documentation, and do not interpret the absence of an observed effect as evidence of universal safety.

5. Can it be combined with other catalog products?

The related links are for navigation and comparison, not a combination protocol. Any proposed combination needs its own scientific rationale, compatibility assessment, controls, and oversight. Sharing a broad research theme does not establish additive effects, synergy, suitable exposure, or safety.

6. How should it be dissolved and stored?

Use instructions applicable to the actual supplied form and a validated laboratory method. Confirm solvent compatibility at the working concentration, label prepared solutions, and follow documented storage conditions. A storage claim for dry material does not automatically apply to a solution or a different formulation.

7. Does a research-use label establish legal permission?

No. A catalog label is not a regulatory determination or permission for clinical use. Before procurement, the responsible institution should verify the requirements applicable to its location, import route, and intended research. This page does not provide jurisdiction-specific legal advice or an assurance of authorization.

Research-Only Summary

5-Amino-1MQ is best evaluated through three separate checks: confirmed material identity, an appropriate analytical and experimental method, and careful interpretation of preclinical evidence. Use this page as a research-oriented overview and verify batch-dependent properties before use. The cited literature does not certify this product, establish a human treatment, or replace institutional safety and compliance review.